共 160 条
[1]
Kim DY(2007)PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection Oncology 72 52-7
[2]
Paik YH(1986)Amplification and expression of genes associated with multidrug resistance in mammalian cells Science 232 751-5
[3]
Ahn SH(2011)American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 1020-24
[4]
Youn YJ(2008)FDA approves sorafenib for patients with inoperable Liver Diseases. cancer Gastroenterology 134 379-21
[5]
Choi JW(2006)Sorafenib Curr Opin Oncol 18 615-61
[6]
Kim JK(2006)Sorafenib Expert Opin Pharmacother 7 453-7
[7]
Scotto KW(2002)BAY 43-9006: preclinical data Curr Pharm Des 8 2255-9
[8]
Biedler JL(2005)The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006 Oncogene 24 6861-45
[9]
Melera PW(2012)AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways Hepatology 55 833-6
[10]
Bruix J(2010)Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells Acta Pharmacol Sin 31 361-94